Please enable JavaScript to continue using this application.

Compare $BDTX vs $HUMA | Chartloom

Compare

$BDTX vs $HUMA

Black Diamond Therapeutics Inc · Humacyte Inc

BDTX

Black Diamond Therapeutics Inc

HUMA

Humacyte Inc

Compare $BDTX vs $HUMA

Comparing Black Diamond Therapeutics Inc and Humacyte Inc

BDTXBlack Diamond Therapeutics Inc

HUMAHumacyte Inc

BDTXBlack Diamond Therapeutics Inc

Market cap

$105M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-26.5%

52W performance

-54.1%

FCF yield

-31.3%

HUMAHumacyte Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.62x

Rev growth (TTM)

159.3%

YTD performance

-58.4%

52W performance

-76.0%

FCF yield

-89.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BDTX

HUMA

Detailed metrics comparison

BDTX

Black Diamond Therapeutics Inc

HUMA

Humacyte Inc

Market Cap

BDTX$105M

HUMA$109M

Enterprise Value

BDTX$86M

HUMA$96M

Price

BDTX$1.83

HUMA$0.41

P/E Ratio

BDTXN/A

HUMAN/A

P/S Ratio

BDTX0.00x

HUMA51.53x

EV/Sales

BDTX0.00x

HUMA45.06x

EV/EBITDA

BDTX6.96x

HUMA0.00x

P/B Ratio

BDTX1.13x

HUMA4.63x

P/FCF Ratio

BDTXN/A

HUMAN/A

EV/FCF

BDTX-2.61x

HUMA-0.98x

PEG Ratio

BDTXN/A

HUMAN/A

Forward P/E (NTM)

BDTXN/A

HUMAN/A

Forward P/S (NTM)

BDTXN/A

HUMA14.62x

Revenue (TTM)

BDTX$0

HUMA$2M

Revenue Growth (YoY)

BDTX-100.0%

HUMA159.3%

Forward Rev Growth

BDTX533.3%

HUMA520.3%

Gross Margin (TTM)

BDTX0.0%

HUMA-494.6%

Operating Margin (TTM)

BDTX0.0%

HUMA0.0%

EBITDA Margin (TTM)

BDTX0.0%

HUMA-4900.0%

Net Margin (TTM)

BDTX0.0%

HUMA-4560.8%

FCF Margin (TTM)

BDTXN/A

HUMA-4599.7%

Net Income (TTM)

BDTX$-43M

HUMA$-97M

FCF (TTM)

BDTX$-33M

HUMA$-98M

EPS (TTM)

BDTX-$0.74

HUMA-$0.41

ROE (TTM)

BDTX-3880.0%

HUMA-51675.0%

ROA (TTM)

BDTX-3047.0%

HUMA-8476.0%

ROIC (TTM)

BDTX-3880.0%

HUMA-9784.0%

Cash

BDTX$19M

HUMA$80M

Debt

BDTX$0

HUMA$66M

Net Cash/Debt

BDTX$19M

HUMA$14M

Current Ratio (TTM)

BDTX7.28x

HUMA6.21x

Quick Ratio (TTM)

BDTX6.98x

HUMA5.38x

Debt/Equity (TTM)

BDTX0.00x

HUMA2.12x

Debt/Assets (TTM)

BDTX0.0%

HUMA0.0%

Interest Coverage (TTM)

BDTXN/A

HUMAN/A

Net Debt/EBITDA (TTM)

BDTX0.00x

HUMA0.00x

Beta

BDTX3.41

HUMA2.76

52W Performance

BDTX-54.1%

HUMA-76.0%

YTD Performance

BDTX-26.5%

HUMA-58.4%

% from 52W High

BDTX-63.0%

HUMA-78.6%

% from 52W Low

BDTX14.4%

HUMA3.7%

Asset Turnover (TTM)

BDTX0.00x

HUMA0.02x

FCF Yield (TTM)

BDTX-31.3%

HUMA-89.3%

Earnings Yield (TTM)

BDTX-40.6%

HUMA-88.5%

Dividend Yield (TTM)

BDTXN/A

HUMAN/A

Rule of 40

BDTX-100.0

HUMA-4,440.4

EV/GP/RG

BDTXN/A

HUMAN/A

Ticker research

View BDTX research View HUMA research

Metric	BDTX Black Diamond Therapeutics Inc	HUMA Humacyte Inc
Market & Valuation
Market Cap	$105M	$109M
Enterprise Value	$86M	$96M
Price	$1.83	$0.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	51.53x
EV/Sales	0.00x	45.06x
EV/EBITDA	6.96x	0.00x
P/B Ratio	1.13x	4.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.61x	-0.98x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.62x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	-100.0%	159.3%
Forward Rev Growth	533.3%	520.3%
Profitability
Gross Margin (TTM)	0.0%	-494.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-4900.0%
Net Margin (TTM)	0.0%	-4560.8%
FCF Margin (TTM)	N/A	-4599.7%
Net Income (TTM)	$-43M	$-97M
FCF (TTM)	$-33M	$-98M
EPS (TTM)	-$0.74	-$0.41
ROE (TTM)	-3880.0%	-51675.0%
ROA (TTM)	-3047.0%	-8476.0%
ROIC (TTM)	-3880.0%	-9784.0%
Financial Health
Cash	$19M	$80M
Debt	$0	$66M
Net Cash/Debt	$19M	$14M
Current Ratio (TTM)	7.28x	6.21x
Quick Ratio (TTM)	6.98x	5.38x
Debt/Equity (TTM)	0.00x	2.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.41	2.76
52W Performance	-54.1%	-76.0%
YTD Performance	-26.5%	-58.4%
% from 52W High	-63.0%	-78.6%
% from 52W Low	14.4%	3.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-31.3%	-89.3%
Earnings Yield (TTM)	-40.6%	-88.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-4,440.4
EV/GP/RG	N/A	N/A
Ticker research	View BDTX research	View HUMA research

Valuation

P/S Ratio

BDTX

0.00x

HUMA

51.53x

EV/FCF

BDTX

-2.61x

HUMA

-0.98x

Growth & revenue

Revenue Growth TTM

HUMA

159.3%

BDTX

-100.0%

Forward Revenue Growth

BDTX

533.3%

HUMA

520.3%

Profitability & performance

Gross Margin

BDTX

0.0%

HUMA

-494.6%

ROE

BDTX

-3880.0%

HUMA

-51675.0%

FCF Yield %

BDTX

-31.3%

HUMA

-89.3%

52-Week Performance

BDTX

-54.1%

HUMA

-76.0%

Detailed metrics comparison

BDTX

Black Diamond Therapeutics Inc

HUMA

Humacyte Inc

Market Cap

BDTX$105M

HUMA$109M

Enterprise Value

BDTX$86M

HUMA$96M

Price

BDTX$1.83

HUMA$0.41

P/E Ratio

BDTXN/A

HUMAN/A

P/S Ratio

BDTX0.00x

HUMA51.53x

EV/Sales

BDTX0.00x

HUMA45.06x

EV/EBITDA

BDTX6.96x

HUMA0.00x

P/B Ratio

BDTX1.13x

HUMA4.63x

P/FCF Ratio

BDTXN/A

HUMAN/A

EV/FCF

BDTX-2.61x

HUMA-0.98x

PEG Ratio

BDTXN/A

HUMAN/A

Forward P/E (NTM)

BDTXN/A

HUMAN/A

Forward P/S (NTM)

BDTXN/A

HUMA14.62x

Revenue (TTM)

BDTX$0

HUMA$2M

Revenue Growth (YoY)

BDTX-100.0%

HUMA159.3%

Forward Rev Growth

BDTX533.3%

HUMA520.3%

Gross Margin (TTM)

BDTX0.0%

HUMA-494.6%

Operating Margin (TTM)

BDTX0.0%

HUMA0.0%

EBITDA Margin (TTM)

BDTX0.0%

HUMA-4900.0%

Net Margin (TTM)

BDTX0.0%

HUMA-4560.8%

FCF Margin (TTM)

BDTXN/A

HUMA-4599.7%

Net Income (TTM)

BDTX$-43M

HUMA$-97M

FCF (TTM)

BDTX$-33M

HUMA$-98M

EPS (TTM)

BDTX-$0.74

HUMA-$0.41

ROE (TTM)

BDTX-3880.0%

HUMA-51675.0%

ROA (TTM)

BDTX-3047.0%

HUMA-8476.0%

ROIC (TTM)

BDTX-3880.0%

HUMA-9784.0%

Cash

BDTX$19M

HUMA$80M

Debt

BDTX$0

HUMA$66M

Net Cash/Debt

BDTX$19M

HUMA$14M

Current Ratio (TTM)

BDTX7.28x

HUMA6.21x

Quick Ratio (TTM)

BDTX6.98x

HUMA5.38x

Debt/Equity (TTM)

BDTX0.00x

HUMA2.12x

Debt/Assets (TTM)

BDTX0.0%

HUMA0.0%

Interest Coverage (TTM)

BDTXN/A

HUMAN/A

Net Debt/EBITDA (TTM)

BDTX0.00x

HUMA0.00x

Beta

BDTX3.41

HUMA2.76

52W Performance

BDTX-54.1%

HUMA-76.0%

YTD Performance

BDTX-26.5%

HUMA-58.4%

% from 52W High

BDTX-63.0%

HUMA-78.6%

% from 52W Low

BDTX14.4%

HUMA3.7%

Asset Turnover (TTM)

BDTX0.00x

HUMA0.02x

FCF Yield (TTM)

BDTX-31.3%

HUMA-89.3%

Earnings Yield (TTM)

BDTX-40.6%

HUMA-88.5%

Dividend Yield (TTM)

BDTXN/A

HUMAN/A

Rule of 40

BDTX-100.0

HUMA-4,440.4

EV/GP/RG

BDTXN/A

HUMAN/A

Ticker research

View BDTX research View HUMA research

Metric	BDTX Black Diamond Therapeutics Inc	HUMA Humacyte Inc
Market & Valuation
Market Cap	$105M	$109M
Enterprise Value	$86M	$96M
Price	$1.83	$0.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	51.53x
EV/Sales	0.00x	45.06x
EV/EBITDA	6.96x	0.00x
P/B Ratio	1.13x	4.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.61x	-0.98x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.62x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	-100.0%	159.3%
Forward Rev Growth	533.3%	520.3%
Profitability
Gross Margin (TTM)	0.0%	-494.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-4900.0%
Net Margin (TTM)	0.0%	-4560.8%
FCF Margin (TTM)	N/A	-4599.7%
Net Income (TTM)	$-43M	$-97M
FCF (TTM)	$-33M	$-98M
EPS (TTM)	-$0.74	-$0.41
ROE (TTM)	-3880.0%	-51675.0%
ROA (TTM)	-3047.0%	-8476.0%
ROIC (TTM)	-3880.0%	-9784.0%
Financial Health
Cash	$19M	$80M
Debt	$0	$66M
Net Cash/Debt	$19M	$14M
Current Ratio (TTM)	7.28x	6.21x
Quick Ratio (TTM)	6.98x	5.38x
Debt/Equity (TTM)	0.00x	2.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.41	2.76
52W Performance	-54.1%	-76.0%
YTD Performance	-26.5%	-58.4%
% from 52W High	-63.0%	-78.6%
% from 52W Low	14.4%	3.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-31.3%	-89.3%
Earnings Yield (TTM)	-40.6%	-88.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-4,440.4
EV/GP/RG	N/A	N/A
Ticker research	View BDTX research	View HUMA research